Hanmi Pharm. Co., Ltd. (KRX:128940)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Reconciliation of Inter-Sector Transactions	-113.14B	-114.82B	-101.69B	-89.72B	-89.38B
Overseas Medicine	385.63B	397.69B	350.64B	288.73B	203.53B
Overseas Medicine Growth	-3.03%	13.42%	21.44%	41.86%	-20.00%
Medicine	1.11T	1.10T	982.05B	917.02B	872.40B
Medicine Growth	1.57%	11.70%	7.09%	5.11%	1.01%
Raw Drug Substance	108.89B	111.07B	100.55B	87.16B	89.29B
Raw Drug Substance Growth	-1.96%	10.46%	15.36%	-2.39%	-19.07%
Total	1.50T	1.49T	1.33T	1.20T	1.08T
Total Growth	0.31%	11.97%	10.67%	11.84%	-3.39%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Republic of Korea	918.60B	890.76B	826.08B	768.94B	705.97B
Republic of Korea Growth	3.13%	7.83%	7.43%	8.92%	4.05%
Other	77.96B	75.48B	63.69B	44.14B	51.97B
Other Growth	3.29%	18.51%	44.29%	-15.07%	-18.69%
China	391.93B	404.85B	356.11B	321.56B	220.71B
China Growth	-3.19%	13.69%	10.75%	45.69%	-19.90%
Japan	56.13B	51.81B	44.80B	41.13B	52.18B
Japan Growth	8.33%	15.65%	8.93%	-21.18%	-8.29%
The United States of America	50.88B	67.99B	40.87B	27.43B	45.03B
The United States of America Growth	-25.16%	66.36%	49.00%	-39.09%	16.11%
Total	1.50T	1.49T	1.33T	1.20T	1.08T
Total Growth	0.31%	11.97%	10.67%	11.84%	-3.39%

Source: S&P Global Market Intelligence.